Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
-
181
-
182
Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR.
Published 2024Subjects: -
183
-
184
WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression.
Published 2024“…Corresponding densitometry analysis is noted as protein fold expression compared to GAPDH for WT1, p<0.001(***), vFLIP(ns), LANA p<0.05(*), pAKT p<0.05(*), and BCL2 p <0.05(*) using two-sided, unpaired student t-tests. …”
-
185
-
186
-
187
Genes whose expression was decreased in RASMC subjected to Na<sup>+</sup>,K<sup>+</sup>-ATPase inhibition.
Published 2014“…Listed are assigned genes whose expression was decreased in K<sup>+</sup>-free medium by more than 3-fold and was different by less than 2-fold in the presence of ouabain compared to K<sup>+</sup>-free medium. …”
-
188
Assessment of cell proliferation within the vocal fold muscle following DFATs transplantation.
Published 2025Subjects: -
189
Analysis of apoptotic cells within the vocal fold muscle following DFATs transplantation.
Published 2025Subjects: -
190
-
191
-
192
-
193
-
194
-
195
CD34<sup>+</sup> cell populations decreased in malaria.
Published 2015“…(B) Circulating EPC numbers (CD45<sup>-</sup>CD34<sup>+</sup>VEGFR2<sup>+</sup>) are decreased in malaria patients by 1.7-fold compared with non-malaria. …”
-
196
VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival.
Published 2018“…Data for cancer subtypes are shown in boxes numbered 1–11: 1: benign breast neoplasm (rank 6459, 1.4 fold-change, NS), 2: breast carcinoma (rank 833, 1.5 fold-change, p = 3.83x10<sup>-5</sup>), 3: breast phyllodes tumor (rank 512, 1.2 fold-change, p = 0.002), 4: ductal breast carcinoma in situ (rank 1969, 1.5 fold-change, p = 0.002), 5: invasive breast carcinoma (rank 1060, 1.6 fold-change, p = 1.28x10<sup>-5</sup>), 6: invasive ductal and invasive lobular breast carcinoma (rank 941, 1.5 fold-change, p = 6.76x10<sup>-22</sup>), 7: invasive ductal breast carcinoma (rank 613, 1.5-fold change, p = 2.71x10<sup>-71</sup>), 8: invasive lobular breast carcinoma (rank 947, 1.3 fold-change, p = 3.64x10<sup>-28</sup>), 9: medullary breast carcinoma (rank 400, 1.8 fold-change, p = 3.25x10<sup>-12</sup>), 10: mucinous breast carcinoma (rank 1932, 1.4 fold-change, p = 7.41x10<sup>-10</sup>) and 11: tubular breast carcinoma (rank 1253, 1.4 fold-change, p = 1.24x10<sup>-17</sup>). …”
-
197
-
198
-
199
-
200
Decreased splicing efficiency in DENV infected cells.
Published 2016“…On the lower panel, increase or decrease retention of introns for each time point is shown.…”